Pre-exposure (PrEP)
Pre-exposure Prophylaxis (PrEP)
IAS 2011: Studies Confirm PrEP, Early ART Prevent HIV Transmission [VIDEO]
- Details
- Category: HIV Prevention
- Published on Monday, 18 July 2011 00:00
- Written by Liz Highleyman
Researchers at the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) taking place this week in Rome presented eagerly awaited data from 3 large trials showing that starting combination antiretroviral therapy (ART) early, and pre-exposure prophylaxis (PrEP) using tenofovir/emtricitabine, can dramatically cut the risk of HIV transmission.
IAS 2011: Biomedical Prevention a Watershed, Global Access Remains Elusive
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Sunday, 17 July 2011 01:00
- Written by Liz Highleyman
The 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) opened Sunday with applause for recent breakthroughs in biomedical prevention of HIV transmission, coupled with acknowledgement that much remains to be done to bring the benefits of science to people with and at risk for HIV/AIDS worldwide. 
Debate over Treatment for Prevention Continues
- Details
- Category: Treatment as Prevention
- Published on Friday, 15 July 2011 00:00
- Written by Matt Sharp
The ongoing debate about whether to start antiretroviral therapy with a CD4 cell count above 500 cells/mm3 for HIV positive people, as well as the widespread use of treatment for prevention in HIV negative people, has been inflamed by results from the HPTN 052 trial. 
IAS 2011: AIDS is at a Scientific Watershed [VIDEO]
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Sunday, 17 July 2011 00:00
- Written by Gregory Fowler
Speaking Sunday at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) opening plenary and press conference, IAS President and conference co-chair Elly Katabira underlined recent advances in biomedical prevention, including findings from the iPrEx, Partners PrEP and TDF2, and HPTN 052 trials showing that pre-exposure prophylaxis and early treatment can reduce HIV transmission. 
IAS 2011: Expand Treatment for Prevention, Experts Urge
- Details
- Category: Pre-exposure Prophylaxis (PrEP)
- Published on Friday, 15 July 2011 00:00
- Written by Press Release
Experts from the International AIDS Society (IAS) and UNAIDS expressed support for an editorial comment by Julio Montaner in the forthcoming issue of The Lancet, calling for expansion of early antiretroviral therapy as one strategy in a comprehensive approach to prevention of HIV infection.
Web Design and Development by